% alzhub.org library filter
% Source: https://alzhub.org/research?author=Fortea+J
% 14 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{fortea2024-38710950,
  author  = {Fortea, J. and Pegueroles, J. and Alcolea, D. and Belbin, O. and Dols-Icardo, O. and Vaqué-Alcázar, L. and Videla, L. and Gispert, J. D. and others},
  title   = {{APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02931-w},
  pmid    = {38710950},
  url     = {https://doi.org/10.1038/s41591-024-02931-w}
}

@article{rubenstein2024-39312235,
  author  = {Rubenstein, E. and Tewolde, S. and Michals, A. and Weuve, J. and Fortea, J. and Fox, M. P. and Pescador Jimenez, M. and Scott, A. and others},
  title   = {{Alzheimer Dementia Among Individuals With Down Syndrome}},
  journal = {JAMA network open},
  year    = {2024},
  doi     = {10.1001/jamanetworkopen.2024.35018},
  pmid    = {39312235},
  url     = {https://doi.org/10.1001/jamanetworkopen.2024.35018}
}

@article{fortea2018-30172624,
  author  = {Fortea, J. and Carmona-Iragui, M. and Benejam, B. and Fernández, S. and Videla, L. and Barroeta, I. and Alcolea, D. and Pegueroles, J. and others},
  title   = {{Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study}},
  journal = {The Lancet. Neurology},
  year    = {2018},
  doi     = {10.1016/s1474-4422(18)30285-0},
  pmid    = {30172624},
  url     = {https://doi.org/10.1016/s1474-4422(18)30285-0}
}

@article{fortea2024-3b742ebe,
  author  = {Fortea, J. and Pegueroles, J. and Alcolea, D. and others},
  title   = {{APOE4 homozygosity represents a distinct genetic form of Alzheimer's disease}},
  journal = {Nature Medicine},
  year    = {2024}
}

@article{suarezcalvet2016-26941262,
  author  = {Suárez-Calvet, M. and Kleinberger, G. and MÁ, Araque Caballero and Brendel, M. and Rominger, A. and Alcolea, D. and Fortea, J. and Lleó, A. and others},
  title   = {{sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201506123},
  pmid    = {26941262},
  url     = {https://doi.org/10.15252/emmm.201506123}
}

@article{faura2020-31958084,
  author  = {Faura, J. and Bustamante, A. and Penalba, A. and Giralt, D. and Simats, A. and Martínez-Sáez, E. and Alcolea, D. and Fortea, J. and others},
  title   = {{CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2020},
  doi     = {10.3233/jad-190753},
  pmid    = {31958084},
  url     = {https://doi.org/10.3233/jad-190753}
}

@article{fortea2021-34687637,
  author  = {Fortea, J. and Zaman, S. H. and Hartley, S. and Rafii, M. S. and Head, E. and Carmona-Iragui, M.},
  title   = {{Alzheimer's disease associated with Down syndrome: a genetic form of dementia}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00245-3},
  pmid    = {34687637},
  url     = {https://doi.org/10.1016/s1474-4422(21)00245-3}
}

@article{fortea2014-24852682,
  author  = {Fortea, J. and Vilaplana, E. and Alcolea, D. and Carmona-Iragui, M. and Sánchez-Saudinos, M. B. and Sala, I. and Antón-Aguirre, S. and González, S. and others},
  title   = {{Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease}},
  journal = {Annals of neurology},
  year    = {2014},
  doi     = {10.1002/ana.24186},
  pmid    = {24852682},
  url     = {https://doi.org/10.1002/ana.24186}
}

@article{garciaayllon2017-28559572,
  author  = {García-Ayllón, M. S. and Lopez-Font, I. and Boix, C. P. and Fortea, J. and Sánchez-Valle, R. and Lleó, A. and Molinuevo, J. L. and Zetterberg, H. and others},
  title   = {{C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease}},
  journal = {Scientific reports},
  year    = {2017},
  doi     = {10.1038/s41598-017-02841-7},
  pmid    = {28559572},
  url     = {https://doi.org/10.1038/s41598-017-02841-7}
}

@article{rubenstein2025-41105592,
  author  = {Rubenstein, E. and Tewolde, S. and Michals, A. and Fortea, J. and Jimenez, M. P. and Skotko, B. G. and Tripodis, Y. and Weuve, J. and others},
  title   = {{Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251385423},
  pmid    = {41105592},
  url     = {https://doi.org/10.1177/13872877251385423}
}

@article{moreau2022-35740400,
  author  = {Moreau, M. and Carmona-Iragui, M. and Altuna, M. and Dalzon, L. and Barroeta, I. and Vilaire, M. and Durand, S. and Fortea, J. and others},
  title   = {{DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients}},
  journal = {Biomedicines},
  year    = {2022},
  doi     = {10.3390/biomedicines10061380},
  pmid    = {35740400},
  url     = {https://doi.org/10.3390/biomedicines10061380}
}

@article{carmonairagui2019-31278851,
  author  = {Carmona-Iragui, M. and Videla, L. and Lleó, A. and Fortea, J.},
  title   = {{Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis}},
  journal = {Developmental neurobiology},
  year    = {2019},
  doi     = {10.1002/dneu.22709},
  pmid    = {31278851},
  url     = {https://doi.org/10.1002/dneu.22709}
}

@article{dammer2026-827b8960,
  author  = {Dammer, E. B. and Afshar, S. and Bian, S. and Seyfried, N. T. and Levey, A. I. and Fortea, J. and Johnson, E. C.},
  title   = {{Plasma Proteomic Analysis of APOE ε4 Homozygotes Identifies Preclinical Alzheimer’s Disease Alterations Potentially Modulated by Semaglutide}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.02.14.26346321},
  url     = {https://doi.org/10.64898/2026.02.14.26346321}
}

@article{tewolde2026-e7d4e2b2,
  author  = {Tewolde, S. and Rosellini, A. J. and Michals, A. and Skotko, B. G. and Fortea, J. and Khor, B. and Handelman, S. and Rubenstein, E.},
  title   = {{Death in People with Down syndrome: Mortality statistics and novel predictors in US Medicaid and Medicare enrolled adults}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.07.17.26358090},
  url     = {https://doi.org/10.64898/2026.07.17.26358090}
}